PULMONX CORP shareholders Q2 2023

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

PULMONX CORP shareholders Q2 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$789,27414.32%
KPCB XIII Associates, LLC 994,971$13,044,0705.83%
PURA VIDA INVESTMENTS, LLC 636,408$8,343,3091.10%
CFM WEALTH PARTNERS LLC 264,039$3,461,5510.84%
BRAIDWELL LP 999,362$13,101,6360.43%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,064,285$13,952,7760.30%
Rock Springs Capital Management LP 652,400$8,552,9640.20%
Olympiad Research LP 13,210$173,1830.17%
Point72 Asset Management, L.P. 3,326,065$43,604,7120.13%
Soleus Capital Management, L.P. 41,000$537,5100.06%
PRIMECAP MANAGEMENT CO/CA/ 5,519,721$72,363,5420.06%
PDT Partners, LLC 31,569$413,8700.06%
ALGERT GLOBAL LLC 93,733$1,2290.05%
Versor Investments LP 22,823$299,2100.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 680,545$8,921,9450.05%
Campbell & CO Investment Adviser LLC 19,361$253,8230.04%
BNP Paribas Asset Management Holding S.A. 907,792$11,9010.04%
Leucadia National 285,110$3,737,7920.03%
Woodline Partners LP 192,173$2,519,3880.03%
OCCUDO QUANTITATIVE STRATEGIES LP 18,232$239,0220.02%
External links

This page lists PULMONX CORP's shareholders in Q2 2023. To view PULMONX CORP's shareholder history, click here.